Cardinal Health, BD, F. Hoffman- La Roche Ltd. are dominating the Global Capillary Blood Collection and Sampling Devices Market in 2019

Global Capillary Blood Collection and Sampling Devices Market is expected to grow with the CAGR of 5.7% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Reports @

Global capillary blood collection and sampling devices market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.    

The major players dealing in global capillary blood collection and sampling devices market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement into the market. This helped companies to maximize the sales with enhanced product portfolio. For instance, in March, 2020 BD fully acquired NAT diagnostics. This will helped the company to expand its point of care portfolio for capillary blood collection and sampling devices and hence lead the company to enhance its revenue.

Cardinal Health is the dominating player in global capillary blood collection and sampling devices market. The other key players existing in the market includes Akacia Medical,  HTL-STREFA, Sarstedt AG & Co. KG, Thermo Fisher Scientific Inc., BD, B. Braun Melsungen AG, Terumo Medical Corporation, Chembio Diagnostic Systems, Inc., Owen Mumford Ltd, Neoteryx, LLC, Greiner Bio-One International GmbH, Improve Medical, KABE LABORTECHNIK GmbH, Nipro Europe Group Companies (A Subsidiary of Nipro Corporation), Radiometer Medical ApS  (A Subsidiary of Danaher), FL MEDICAL s.r.l.,  SureScreen Diagnostics Ltd, F. Hoffmann-La Roche Ltd, Ypsomed AG, Creative Diagnostics, Elabscience, Inc.,  Mologic, Tasso, Inc., Abbott, Vitrex Medical A/S, Disera Medical Equipment Logistics Industry and Trade Inc., AccuBioTech Co., Ltd., CHENGDU RICH SCIENCE INDUSTRY CO., LTD and BIOMEDOMICS INC. among others.

Capillary Blood Collection and Sampling Devices MarketCardinal Health

Cardinal Health headquartered is in Ohio, the U.S. The company offers services and complimentary products to manufacturers and healthcare providers. The offers its products in different categories such as medical products, professionals products in which the market focused segment is medical products. The company generates its revenue through its various subsidiaries including Abilene Nuclear, LLC (Delaware), Allegiance 1, LLC (Delaware), Almus Pharmaceuticals Singapore Pte. Ltd. (Singapore), C. International, Inc (Ohio) among others. It has wide presence in Americas, Asia-Pacific, Europe, Middle East and Africa.

  • In May 2007, Cardinal Health signed an acquisition agreement with VIASYS, a company which is engaged in manufacturing of diagnostics solutions. As the capillary blood collection devices are used for diagnosis of various kinds of disease, this acquisition has helped the company to enhance its platform for capillary blood collection devices, moreover helped the company to earn immediate revenues.


BD headquartered in New Jersey, U.S. was founded in 1897. The company focuses on instruments used for diagnostic infectious disease. The company offers variety of products such as direct testing products, environmental systems, and prepared media products among others. The company operates in two business segment that are medical, life sciences and interventional in which market focused segment is life sciences. The company has wide product portfolio including anesthesia delivery, biosciences, biosurgery, cervical cancer screening, diabetes care, drug delivery systems, gastrointestinal care, hazardous drug safety, hernia repair and fixation, home care, infection prevention, infusion therapy, interventional specialties, lab automation, medication and supply management, microbiology solutions, molecular diagnostics, patient monitoring and temperature management, prostate health, respiratory care, sharps disposal solutions, software solutions, specimen collection, surgical instruments, syringes and needles, urology and kidney health, vascular access, vascular surgery, wound care, in which specimen collection, syringes and needles are the market focused product category. The company has wide presence across North America, South America, Europe, Asia-Pacific, Middle East and Africa. The company also has various subsidiary companies such as Accuri Cytometers, Inc.(Delaware), Accuri Cytometers (Europe), Ltd. (U.K.), Atto Bioscience, Inc. (Delaware), B-D (Cambridge U.K.) Ltd. (U.K.) among others.  

  • In December 2017, BD has completed the acquisition of C. R. Bard, Inc, a company to be health care provider. BD is engaged in offering wide product portfolio of capillary blood collection and sampling devices. This acquisition helped the company to improve its portfolio for both physicians and patients, which ultimately led to earn more revenue.

F. Hoffmann-La Roche Ltd

F. Hoffmann-La Roche Ltd headquartered in Basel, Switzerland was founded in 1896. The company is engaged in creating innovative medicines and diagnostics tests that help millions of people worldwide. The company operates its business in two segments which are pharmaceuticals, diagnostics; corporate in which diagnostics is the market focused segment. The company is engaged in providing wide range of product categories such as core lab, molecular lab, pathology, blood screening, LDT, point of care, next-generation sequencing, harmony prenatal testing in which point of care is the market focused product category.

  • In August 2016, F. Hoffmann-La Roche Ltd launched Accu- Check Guide, the next generation blood glucose monitoring system. This device has utilized the capillary blood collected by using ACCU-CHEK Safe-T-Pro Plus Lancet. This launch helped the company to broaden its product portfolio of capillary blood collection devices.

The company has wide presence across Americas, Europe, Africa, and Asia-Pacific. The company also has various subsidiary companies such as Bina Technologies, Inc. (Belmont), BioVeris Corporation (Indianapolis), Foundation Medicine Securities Corporation (Cambridge), Genentech USA, Inc (South San Francisco), Hoffmann-La Roche Inc (Little Falls), Roche Diagnostics Corporation (Indianapolis) among others.